Anat Nursella

Bio

Anat is a Venture Partner with OrbiMed and joined the firm in 2021. Anat has over 17 years of broad experience in senior financial and operational positions. These have included public and private biotechnology companies supporting fund raising, licensing, partnerships, and M&A transactions with total value exceeding billion USD. Prior to joining OrbiMed, she served as a CFO of ImmPact Bio, Adicet Bio, cCam Biotherapeutics Ltd (acquired by Merck), Keystone Heart Ltd (acquired by Venus Medtech), RDD Pharma Ltd , OticPharma Ltd, NasVax Ltd, Elutex Ltd, and serves as a Director on several company boards. Anat holds the MA Law degree from Bar-Ilan University and BA, Finance and Economics degree from the University of Haifa. She is a Certified Public Accountant. Outside the office, Anat can be found spending time with her family and friends, immersing herself in a good book, and hiking through nature trails.